This module will offer an update on primary care rheumatology during the COVID-19 pandemic, with particular focus on the risks of prescribing disease modifying anti rheumatic drugs (DMARDs) and managing comorbidities associated with inflammatory arthritis.
Supported by an independent education grant from Pfizer Inc. Pfizer has had no involvement in the content.

Curriculum: Musculoskeletal Health
Time to complete this course: 30 minutes
Date of publication: 15 July 2021
Mode: Course
Podcast icon: No
Course index: Show
Section titles: Hide